Quantitative research
Use AxonX to turn research steps into Tasks with explicit inputs, inspectable artifacts, and upstream relationships. Start with a working service and the demo tutorial. Research algorithms and data requirements belong to installed plugins.
Choose the next step
| Goal | Guide | Result |
|---|---|---|
| Execute the Alpha158 chain | Research workflow | Successful ETL → Train → Predict → Backtest records |
| Prepare historical data | Tushare data | Raw partitions and master data covering the experiment |
| Inspect stage outputs | Reading results | Feature, model, prediction, and backtest evidence |
| Evaluate a change | Experiment design | Controls, ablations, a locked candidate, and independent confirmation |
| Interpret portfolio metrics | Backtest methodology | Returns, costs, drawdown, and execution assumptions |
| Compare two strategies | Strategy comparison | Metrics over common valid dates |
Factor analysis branches from ETL independently; it is not required before training. Submission returns a handle; wait for that execution to succeed before passing its Task ID downstream. Lineage records dependencies without automatically scheduling the chain.
Choose a research plugin
Plugin management explains installation and discovery in the execution environment. Alpha158 provides the baseline price/volume features, LightGBM training, and TopN backtest. Alpha158 Enhanced adds independently registered Tasks and configurable feature groups.
Discover the installed Task schemas before submitting. Keep parameters, algorithms, and artifact definitions with the plugin; use research artifact contracts when implementing outputs for Studio.
Follow the agent-developed experiment
The README benchmark follows Codex developing a separate plugin, running ablations, locking a configuration, and checking an independent period. Confirmation-period Top10 net annualized return rose from −5.74% to 28.21%, and Top20 from −3.24% to 24.93%.
Read experiment design for the reusable method and the plugin's complete results for recorded evidence. For agent access, continue with external agents.